Join for free and get access to the buyside
Get insights from the world's most influential hedge fund investors direct to your inbox
- © 2025 Buyside Digest
- Privacy Policy
- Disclaimer
- Sitemap
- Terms of Service
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2024 Q2 | Jun 30, 2024 | LMN Capital | - | 0.5% | ABYY.DE, ARL.DE, BNTX, FMX, IBKR, MTX.DE, PYPL, TCX.TO, WINE.L | Concentration, Europe, Long Term, Owner Managed, value | Aareal Bank faced market stress due to exposure to US office properties, creating a mispricing opportunity. The bank held EUR 3.2 billion in US office loans representing 10% of total portfolio, with strong equity ratios and defensive positioning making the stress temporary rather than systemic. | MTX.DE FMSAUBD.MX AAREAL.DE |
View |
| 2024 Q4 | Dec 31, 2024 | LMN Capital | - | 16.9% | ABYY.DE, ARL.DE, BNTX, FMX, IBKR, MTX.DE, PYPL, ROVI.MC, TCX, UTDI.DE | Europe, Long Term, Owner Led, Pharmaceuticals, technology, Telecommunications, value | Rovi operates contract manufacturing for pharmaceutical companies, with many well-known drug manufacturers outsourcing production to specialized providers. Regulatory oversight makes switching CMO partners lengthy and complex, creating competitive moats. Rovi announced a major new client with production starting in 2026. | UTDI.DE ROVI.MC |
View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| No pitches found. | |||||||||
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||